TTF: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 March 2025

  • curprev 21:0821:08, 8 March 2025Lazy talk contribs 4,217 bytes +4,217 Created page with "{{TreatmentInfo |drug_name=Tumor Treating Fields (TTFields) |FDA_approval=Yes |used_for=Newly diagnosed and recurrent glioblastoma; malignant pleural mesothelioma |clinical_trial_phase=Approved; ongoing Phase III trials for other tumor types |clinical_trial_explanation=TTFields have undergone extensive clinical evaluation, including the EF-14 Phase III trial, which demonstrated a significant survival benefit in newly diagnosed glioblastoma patients when combined with tem..."